UNDERWRITER COMMON SHARE PURCHASE WARRANT IMMUNOPRECISE ANTIBODIES LTD.ImmunoPrecise Antibodies Ltd. • February 4th, 2021 • Pharmaceutical preparations • New York
THIS UNDERWRITER COMMON SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after February 8, 2021 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on February 3, 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from ImmunoPrecise Antibodies Ltd. (the “Company”), a corporation incorporated under the Business Corporations Act (British Columbia) up to ______ common shares (as subject to adjustment hereunder, the “Warrant Shares”) in the capital of the Company. The purchase price of one Common Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain Amended and Restated Underwriting Agreement, by and between the Company and H.C. Wainwright & Co.,
AT THE MARKET OFFERING AGREEMENT October 13, 2021Market Offering Agreement • October 13th, 2021 • ImmunoPrecise Antibodies Ltd. • Pharmaceutical preparations • New York
ImmunoPrecise Antibodies Ltd., a corporation incorporated under the Business Corporations Act (British Columbia) (the “Company”), confirms its agreement (this “Agreement”) with H.C. Wainwright & Co., LLC (the “Manager”) as follows:
UNDERWRITING AGREEMENT between IMMUNOPRECISE ANTIBODIES LTD. and THE BENCHMARK COMPANY LLC as Representative of the Several UnderwritersUnderwriting Agreement • December 6th, 2023 • ImmunoPrecise Antibodies Ltd. • Pharmaceutical preparations • New York
The Benchmark Company LLC As Representative of the several Underwriters named on Schedule 1 attached hereto 150 E. 58th Street, 17th Floor
OPEN MARKET SALE AGREEMENTSMOpen Market Sale • August 16th, 2023 • ImmunoPrecise Antibodies Ltd. • Pharmaceutical preparations • New York
ImmunoPrecise Antibodies Ltd., a corporation continued under the Business Corporations Act (British Columbia) (the "Company"), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the "Agent"), common shares of the Company, without par value (the "Common Shares"), on the terms set forth in this agreement (this "Agreement").
SALES AGREEMENTSales Agreement • February 23rd, 2024 • ImmunoPrecise Antibodies Ltd. • Pharmaceutical preparations • New York
ImmunoPrecise Antibodies Ltd., a corporation continued under the Business Corporations Act (British Columbia) (the "Company"), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Clear Street LLC, as sales agent and/or principal (the "Agent"), common shares of the Company, without par value (the "Common Shares"), on the terms set forth in this agreement (this "Agreement").
AMENDED AND RESTATED UNDERWRITING AGREEMENTUnderwriting Agreement • February 4th, 2021 • ImmunoPrecise Antibodies Ltd. • Pharmaceutical preparations • New York
This Lock-Up Agreement (this “Agreement”) is being delivered to you in connection with the proposed Underwriting Agreement (the “Underwriting Agreement”) between ImmunoPrecise Antibodies Ltd., a corporation incorporated under the Business Corporations Act (British Columbia) (the “Company”), and H.C. Wainwright & Co. LLC (“Wainwright”), as manager of a group of underwriters (collectively, the “Underwriters”), to be named therein, and the other parties thereto (if any), relating to the proposed public offering of common shares (the “Common Shares”), of the Company.
IMMUNOPRECISE ANTIBODIES LTD. as Issuer and [ ] as U.S. Trustee and [ ] as Canadian Trustee Indenture Dated as of [ ], 2023ImmunoPrecise Antibodies Ltd. • July 11th, 2023 • Pharmaceutical preparations • New York
This Indenture is subject to the provisions of Trust Indenture Legislation that are required to be part of this Indenture and shall, to the extent applicable, be governed by such provisions.
SHARE EXCHANGE AGREEMENTExchange Agreement • September 16th, 2020 • ImmunoPrecise Antibodies Ltd.
IMMUNOPRECISE ANTIBODIES LTD., a company duly formed under the laws of the Province of British Columbia, with its principal office located at Unit 3204, 4464 Markham Street, Victoria, BC V8Z 7X8
DATED 14th MARCH 2019 IMMUSYS B.V. and MODIQUEST RESEARCH B.V. and IMMULEASE B.V. and MR JOS RAATS and IMMUNOPRECISE NETHERLANDS B.V. and IMMUNOPRECISE ANTIBODIES LTD. AMENDMENT, TERMINATION AND SETTLEMENT AGREEMENTTermination and Settlement Agreement • September 16th, 2020 • ImmunoPrecise Antibodies Ltd.
ModiQuest Research, Immulease, ImmunoPrecise Netherlands and ImmunoPrecise Antibodies are hereinafter jointly also referred to as the IPA Group Companies and each also an IPA Group Company. The IPA Group Companies, Immusys and Raats are hereinafter jointly referred to as the Parties and each as a Party.
AGREEMENT OF PURCHASE AND SALE OF SHARES OF BIOSTRAND BV - and - BIOKEY BV - and - BIOCLUE BV Made on March 29th, 2022 By and among CHARMQUARK EEN - and - CHARMQUARK TWEE - and - K&E BV as Vendors - and - IMMUNOPRECISE NETHERLANDS B.V. as Purchaser -...Agreement of Purchase and Sale • April 14th, 2022 • ImmunoPrecise Antibodies Ltd. • Pharmaceutical preparations
SHAREHOLDER RIGHTS PLAN AGREEMENT BETWEEN IMMUNOPRECISE ANTIBODIES LTD. AND COMPUTERSHARE TRUST COMPANY OF CANADA Made as of October 17, 2019Shareholder Rights Plan Agreement • September 16th, 2020 • ImmunoPrecise Antibodies Ltd. • British Columbia
WHEREAS the board of directors of the Corporation has determined that it is in the best interests of the Corporation to adopt a shareholder rights plan in order to ensure, to the extent possible, that: (i) all shareholders of the Corporation are treated fairly in connection with any Offer to Acquire the outstanding Voting Shares, and (ii) the board of directors of the Corporation has the opportunity to identify, solicit, develop and negotiate value-enhancing alternatives, as appropriate, to any unsolicited Offer to Acquire the outstanding Voting Shares.
SHARE PURCHASE AGREEMENTShare Purchase Agreement • September 16th, 2020 • ImmunoPrecise Antibodies Ltd.
IMMUNOPRECISE NETHERLANDS B.V., a company duly formed under the laws of the Netherlands, with its registered office located in Haarlemmermeer, Netherlands, registered with the trade register of the Chamber of Commerce under number 71010149
